{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T00:20:48Z","timestamp":1760833248952,"version":"build-2065373602"},"reference-count":5,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","nmd-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuromuscular Disorders"],"published-print":{"date-parts":[[2024,2]]},"DOI":"10.1016\/j.nmd.2023.11.007","type":"journal-article","created":{"date-parts":[[2023,11,22]],"date-time":"2023-11-22T08:41:31Z","timestamp":1700642491000},"page":"39","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Response to: The use of guidelines to assess the risk of malignant hyperthermia in individuals with a RYR1 variant"],"prefix":"10.1016","volume":"35","author":[{"given":"S.","family":"Herdewyn","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"De Bleecker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.","family":"Janssens","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Symoens","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Milazzo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"De Puydt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.nmd.2023.11.007_bib1001","article-title":"The use of guidelines to assess the risk of malignant hyperthermia in individuals with an RYR1 variant","author":"Voermans","year":"2023","journal-title":"Neuromuscul Disord"},{"issue":"11-12","key":"10.1016\/j.nmd.2023.11.007_bib0001a","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1016\/j.nmd.2022.10.003","article-title":"Risk of malignant hyperthermia in patients carrying a variant in the skeletal muscle ryanodine receptor 1 gene","volume":"32","author":"Janssens","year":"2022","journal-title":"Neuromuscul Disord"},{"issue":"12","key":"10.1016\/j.nmd.2023.11.007_bib0001","doi-asserted-by":"crossref","first-page":"3486","DOI":"10.1111\/ene.15526","article-title":"European Neuromuscular Centre consensus statement on anaesthesia in patients with neuromuscular disorders","volume":"29","author":"van den Bersselaar","year":"2022","journal-title":"Eur J Neurol"},{"issue":"7","key":"10.1016\/j.nmd.2023.11.007_bib0002","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1038\/s41436-021-01125-w","article-title":"Variant curation expert panel recommendations for RYR1 pathogenicity classifications in malignant hyperthermia susceptibility","volume":"23","author":"Johnston","year":"2021","journal-title":"Genet Med: Off J Am Coll Med Genet"},{"issue":"23","key":"10.1016\/j.nmd.2023.11.007_bib0003","doi-asserted-by":"crossref","first-page":"4087","DOI":"10.1093\/hmg\/ddac145","article-title":"Updated variant curation expert panel criteria and pathogenicity classifications for 251 variants for RYR1-related malignant hyperthermia susceptibility","volume":"31","author":"Johnston","year":"2022","journal-title":"Hum Mol Genet"}],"container-title":["Neuromuscular Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960896623007988?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960896623007988?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T08:14:08Z","timestamp":1760775248000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0960896623007988"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2]]},"references-count":5,"alternative-id":["S0960896623007988"],"URL":"https:\/\/doi.org\/10.1016\/j.nmd.2023.11.007","relation":{},"ISSN":["0960-8966"],"issn-type":[{"type":"print","value":"0960-8966"}],"subject":[],"published":{"date-parts":[[2024,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Response to: The use of guidelines to assess the risk of malignant hyperthermia in individuals with a RYR1 variant","name":"articletitle","label":"Article Title"},{"value":"Neuromuscular Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nmd.2023.11.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/j.nmd.2023.10.009","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}